Penn Vice Provost Ezekiel Emanuel named to President-elect Biden’s Transition COVID-19 Advisory Board
Emanuel has been tapped as member of a team of leading public health and scientific experts to advise on the Biden-Harris COVID-19 response.
Ezekiel Emanuel, vice provost for Global Initiatives and chair of the Department of Medical Ethics and Health Policy at the Perelman School of Medicine has been named by President-elect Joe Biden to the coronavirus task force.
(Image: Candace diCarlo)
Bioethicist and oncologist Ezekiel Emanuel, Vice Provost for Global Initiatives and chair of the Department of Medical Ethics and Health Policy at the University of Pennsylvania, has been named to President-elect Joseph R. Biden Jr.’s Transition COVID-19 Advisory Board. The Biden-Harris transition team made the announcement Monday, Nov. 9.
Emanuel served as former adviser to the Obama administration on the Affordable Care Act and as a special adviser for health policy to the director of the White House Office of Management and Budget between January 2009 and January 2011. Since 1997, he has served as chair of the Department of Bioethics at The Clinical Center of the National Institutes of Health.
“It is a great honor to serve President-elect Biden and Vice President-elect Harris to help address this pandemic and get the country moving again,” Emanuel said of the appointment.
The task force is made up leading public health experts and will be co-chaired by David Kessler, Vivek Murthy, and Marcella Nunez-Smith.
“Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science and by experts,” said President-elect Biden in the statement.
Penn physicists led by Bo Zhen have created hybrid light-matter particles that interact strongly enough to compute, pointing toward ultrafast, low-energy optical AI hardware.
Penn’s newest supercomputer is transforming research
Penn’s first campus-wide HPC and AI cluster, “Betty,” is expanding access to powerful computing, enabling groundbreaking projects, and fostering new collaborations across disciplines.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
The performing arts at Penn: Process, practice, and purpose
In the vivid tapestry of performing arts groups at Penn, students prepare for their performances while simultaneously enriching their college experience.
